MEDIFAUCON: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIFAUCON
Largest movements
- Cash +€139,778
up €139,778 (+165%), from €84,575 to €224,354
mainly Net result for the year (+€136,315) and Trade debts (+€26,099)
- Receivables within one year +€35,327
up €35,327 (+77.3%), from €45,689 to €81,017
of which Other amounts receivable: +€18,002
- Profit (loss) carried forward +€136,315
up €136,315 (+140%), from €97,609 to €233,924
- Trade debts +€26,099
up €26,099 (+904%), from €2,887 to €28,986
- Tax, wage and social debts +€13,274
up €13,274 (+45.4%), from €29,236 to €42,510
of which Taxes: +€13,274
- Gross operating margin +€47,638
up €47,638 (+36.8%), from €129,334 to €176,972
- Taxes +€13,524
up €13,524 (+48.6%), from €27,821 to €41,344
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €131,315 | €306,420 | +€175,105 | +133% |
| Current assets | 29/58 | €131,315 | €306,420 | +€175,105 | +133% |
| Amounts receivable within one year | 40/41 | €45,689 | €81,017 | +€35,327 | +77.3% |
| Trade receivables | 40 | €35,955 | €53,281 | +€17,326 | +48.2% |
| Other amounts receivable | 41 | €9,734 | €27,736 | +€18,002 | +185% |
| Cash at bank and in hand | 54/58 | €84,575 | €224,354 | +€139,778 | +165% |
| Deferred charges and accrued income | 490/1 | €1,050 | €1,050 | = | 0.0% |
| Total equity and liabilities | 10/49 | €131,315 | €306,420 | +€175,105 | +133% |
| Equity | 10/15 | €98,609 | €234,924 | +€136,315 | +138% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €97,609 | €233,924 | +€136,315 | +140% |
| Amounts payable | 17/49 | €32,706 | €71,496 | +€38,790 | +119% |
| Amounts payable within one year | 42/48 | €32,706 | €71,496 | +€38,790 | +119% |
| Trade debts | 44 | €2,887 | €28,986 | +€26,099 | +904% |
| Suppliers | 440/4 | €2,887 | €28,986 | +€26,099 | +904% |
| Taxes, remuneration and social security | 45 | €29,236 | €42,510 | +€13,274 | +45.4% |
| Taxes | 450/3 | €28,070 | €41,344 | +€13,274 | +47.3% |
| Remuneration and social security | 454/9 | €1,166 | €1,166 | = | 0.0% |
| Other amounts payable | 47/48 | €583 | €0 | -€583 | -100% |
| Other operating charges | 640/8 | €495 | €309 | -€186 | -37.6% |
| Gross operating margin | 9900 | €129,334 | €176,972 | +€47,638 | +36.8% |
| Operating profit (loss) | 9901 | €128,840 | €176,664 | +€47,824 | +37.1% |
| Financial income | 75/76B | €259 | €1,015 | +€757 | +293% |
| Recurring financial income | 75 | €259 | €1,015 | +€757 | +293% |
| Financial charges | 65/66B | €85 | €19 | -€66 | -77.5% |
| Recurring financial charges | 65 | €85 | €19 | -€66 | -77.5% |
| Profit (loss) for the period before taxes | 9903 | €129,013 | €177,660 | +€48,647 | +37.7% |
| Income taxes | 67/77 | €27,821 | €41,344 | +€13,524 | +48.6% |
| Profit (loss) for the period | 9904 | €101,193 | €136,315 | +€35,123 | +34.7% |
| Profit (loss) for the period to be appropriated | 9905 | €101,193 | €136,315 | +€35,123 | +34.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.